Herceptin

FDA Approves Eighth Biosimilar, First for Cancer Drug Herceptin
RAPS.org
Sat, 12/2/17 - 11:20 am
FDA
biosimilars
Herceptin
Ogivri
Mylan Labs
Biocon
With $2.5B in Herceptin sales on the line, Roche sues Pfizer for biosim patent infringement
Fierce Pharma
Tue, 11/21/17 - 12:14 pm
Herceptin
Roche
Pfizer
biosimilars
breast cancer
Biocon and Mylan say their plant is good to go as FDA decision nears for their Herceptin copy
Fierce Pharma
Tue, 11/21/17 - 11:42 am
Biocon
Mylan Labs
FDA
Herceptin
drug manufacturing
biologics
India
Samsung Bioepis first to secure EMA backing for Herceptin biosimilar
BioPharma Dive
Mon, 09/18/17 - 09:23 am
Samsung Bioepis
EMA
Europe
biosimilars
Herceptin
Roche
breast cancer
Key FDA Regulatory Events to Watch Out for in Sep 2017
Yahoo/Zacks.com
Mon, 09/4/17 - 10:31 pm
FDA
Mylan Labs
Herceptin
biosimilars
trastuzumab
Shingrix
GSK
Pfizer
Sutent
PTC Therapeutics
Translarna
Amgen
Allergan
Avastin
As Roche wades biosimilar waters, more competitors circle Herceptin
BioPharma Dive
Wed, 08/2/17 - 09:28 pm
Roche
Herceptin
biosimilars
Amgen
Allergan
ABP 980
Celltrion
CT-P6
FDA advances two more Herceptin biosims—this time from Amgen and Teva—as Roche braces for impact
Fierce Pharma
Mon, 07/31/17 - 09:56 pm
FDA
Herceptin
biosimilars
Roche
Amgen
Teva Pharmaceutical
Allergan
Celltrion
Poor test results for Roche cloud growth prospects
Yahoo/Reuters
Wed, 07/19/17 - 09:54 am
Roche
biosimilars
Rituxan
Herceptin
Avastin
The biosimilar pack is growing around Roche’s all-star trio, looking to rip into a $21B franchise
Endpoints
Wed, 07/12/17 - 10:36 am
Roche
biosimilars
Avastin
Herceptin
ABP 215
Amgen
MYL-14010
Mylan Labs
Rituxan
The 9 Best-Selling Prescription Drugs in 2016 (Each One Topped $6 Billion)
Motley Fool
Fri, 06/30/17 - 11:06 am
prescription data
Sanofi
Lantus
Roche
Herceptin
Avastin
Celgene
Revlimid
JNJ
Merck
Remicade
Biogen
Rituxan
Amgen
Enbrel
Gilead Sciences
Harvoni
AbbVie
Humira
Amid sales growth, Roche plans defense from biosimilar threats
BioPharma Dive
Fri, 04/28/17 - 10:30 am
Roche
biosimilars
Rituxan
Herceptin
Avastin
3 Big Biotech Stocks With Big-Time Catalysts
Motley Fool
Sun, 04/9/17 - 12:36 pm
Regeneron
Praluent
Amgen
biosimilars
Amjevita
Humira
ABP-215
Avastin
ABP-980
Herceptin
Celgene
ozanimod
The 19 Best-Selling Prescription Drugs of All-Time
Motley Fool
Mon, 03/13/17 - 11:29 am
Lipitor
Humira
Seretide
Remicade
Plavix
Enbrel
Rituxan
Herceptin
Avastin
Nexium
Zyprexa
Roche and Mylan settle a scrap over Herceptin, clearing path to a global launch of a knockoff drug
Endpoints
Mon, 03/13/17 - 10:13 am
Roche
Mylan Labs
Herceptin
Perjeta
breast cancer
Pfizer's Herceptin biosimilar succeeds in key breast cancer study
Yahoo/Reuters
Wed, 11/30/16 - 09:44 pm
Pfizer
biosimilars
Herceptin
PF-05280014
HER2-positive metastatic breast cancer
Teva ponies up $160M-plus for marketing rights to Celltrion's Rituxan, Herceptin biosims
Fierce Pharma
Fri, 10/7/16 - 09:11 am
Teva Pharmaceutical
Celltrion
Rituxan
Herceptin
biosimilars
A Look at Roche’s Potential Revenue Drivers
Market Realist
Tue, 07/26/16 - 11:21 am
Roche
Perjeta
Herceptin
Kadcyla
Amgen and Allergan Study Finds Biosimilar Comparable to Herceptin
WSJ Online
Fri, 07/22/16 - 09:49 am
Amgen
Allergan
biosimilars
Herceptin
ABP 980
Roche
breast cancer
How Mylan Is Taking On One of the World's Top Breast Cancer Drugs
Fortune
Mon, 06/6/16 - 10:36 am
Roche
breast cancer
Herceptin
biosimilars
Mylan Labs
Genentech accused again of cheating health care providers
Stat
Sat, 05/21/16 - 12:38 pm
Genentech
Roche
Herceptin

Pages